BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21192934)

  • 1. Molecular mechanisms of tumor suppression by LKB1.
    Vaahtomeri K; Mäkelä TP
    FEBS Lett; 2011 Apr; 585(7):944-51. PubMed ID: 21192934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LKB1; linking cell structure and tumor suppression.
    Hezel AF; Bardeesy N
    Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor kinase LKB1: lessons from mouse models.
    Ollila S; Mäkelä TP
    J Mol Cell Biol; 2011 Dec; 3(6):330-40. PubMed ID: 21926085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
    Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
    Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.
    Contreras CM; Gurumurthy S; Haynie JM; Shirley LJ; Akbay EA; Wingo SN; Schorge JO; Broaddus RR; Wong KK; Bardeesy N; Castrillon DH
    Cancer Res; 2008 Feb; 68(3):759-66. PubMed ID: 18245476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
    Nony P; Gaude H; Rossel M; Fournier L; Rouault JP; Billaud M
    Oncogene; 2003 Dec; 22(57):9165-75. PubMed ID: 14668798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.
    Carretero J; Medina PP; Pio R; Montuenga LM; Sanchez-Cespedes M
    Oncogene; 2004 May; 23(22):4037-40. PubMed ID: 15021901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LKB1 mutation in large cell carcinoma of the lung.
    Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W
    Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.
    Fernandez P; Carretero J; Medina PP; Jimenez AI; Rodriguez-Perales S; Paz MF; Cigudosa JC; Esteller M; Lombardia L; Morente M; Sanchez-Verde L; Sotelo T; Sanchez-Cespedes M
    Oncogene; 2004 Jun; 23(29):5084-91. PubMed ID: 15077168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.
    Jansen M; Ten Klooster JP; Offerhaus GJ; Clevers H
    Physiol Rev; 2009 Jul; 89(3):777-98. PubMed ID: 19584313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.
    Collins SP; Reoma JL; Gamm DM; Uhler MD
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):673-80. PubMed ID: 10642527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
    Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
    Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
    Zeng PY; Berger SL
    Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
    Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
    Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lkb1 is required for TGFbeta-mediated myofibroblast differentiation.
    Vaahtomeri K; Ventelä E; Laajanen K; Katajisto P; Wipff PJ; Hinz B; Vallenius T; Tiainen M; Mäkelä TP
    J Cell Sci; 2008 Nov; 121(Pt 21):3531-40. PubMed ID: 18840652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma.
    Shen Z; Wen XF; Lan F; Shen ZZ; Shao ZM
    Clin Cancer Res; 2002 Jul; 8(7):2085-90. PubMed ID: 12114407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1.
    Setogawa T; Shinozaki-Yabana S; Masuda T; Matsuura K; Akiyama T
    Biochem Biophys Res Commun; 2006 May; 343(4):1186-90. PubMed ID: 16580634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours.
    Wang ZJ; Churchman M; Campbell IG; Xu WH; Yan ZY; McCluggage WG; Foulkes WD; Tomlinson IP
    Br J Cancer; 1999 Apr; 80(1-2):70-2. PubMed ID: 10389980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients.
    Nezu J; Oku A; Shimane M
    Biochem Biophys Res Commun; 1999 Aug; 261(3):750-5. PubMed ID: 10441497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular mechanisms that underlie the tumor suppressor function of LKB1.
    Fan D; Ma C; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2009 Feb; 41(2):97-107. PubMed ID: 19204826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.